Student mental health crisis worsening nationwide

1. 1 in 5 high school students considered suicide within last year, CDC says Full story

2. The size of 4 big payers’ behavioral provider networks Full story

3. Cherry Health to place Narcan vending machines in Michigan Full story

4. How 4 health systems fill gaps in behavioral health with automated care programs

5. UC San Diego anesthesiologist creates app for fentanyl overdose rescue Full story

6. Viewpoint: NYC’s involuntary hospitalization violates profession’s values Full story

7. The average cost of boarding a psych patient in the ED is $2,264. See 6 ways a comprehensive behavioral health strategy can help hospitals reduce these avoidable costs.

Becker’s Learning Opportunities

1. IU Health isn’t letting data gaps stand in the way of making health equity a reality. Here’s how your health system can do the same.

2. How healthy is your workforce? These programs can help empower healthcare workers to improve their health and better serve patients.

3. Compensation alone can’t solve hospital workforce shortages — leaders need new ideas. Find inspiration in these 10 articles about coping with talent shortages.

Leave a Comment

Your email address will not be published. Required fields are marked *

Add Comment *

Name *

Email *

Website

Keep Reading: Related Posts

Top 10 Healthy Personality Traits That Are Key To Your Psychological Well-Being
Tehrene Firman August 09, 2022 Publisher note: Take advantage of our messaging and live one-on-one video connect offered by your provider! If HereNOW Help is new to you and you...
Media and The Portrayal of Mental Illness Disorders
Integrative Life Center Movies and television shows, as well as other forms of entertainment, have the ability to shape how we see the world. However, the portrayal of mental illness...
A Single Dose of Psilocybin for Treatment-Resistant Depression
Leah Kuntz A single dose of psilocybin could help patients with treatment-resistant depression, according to a new study. According to the results of a phase 2b trial of COMP360 psilocybin...
Skip to content